Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Katsuo Amioka"'
Autor:
Takafumi Kuzuya, Yoshihiko Watarai, Akio Katayama, Takaaki Kobayashi, Kazuharu Uchida, Yuko Miwa, Kiyofumi Yamada, Kenta Iwasaki, Masataka Haneda, Katsuo Amioka, Yoko Kurata
Publikováno v:
International Immunopharmacology. 22:384-391
Although therapeutic drug monitoring based on blood concentration has been widely implemented in transplant recipients treated with immunosuppressive agents, clinical adverse events such as rejection, infection or drug-induced toxicity caused by inap
Autor:
Shunichi Fukuhara, Kazuhiro Watanabe, Misa Takegami, Yuko Sekine, Keiko Sato, Yoshihiro Onishi, Yoko Yokoyama, Katsuo Amioka
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 36:277-283
We investigated levels of interest in clinical research among pharmacists working in the clinical field,and specific needs for education to nurture clinical researchers.For this purpose,we conducted a questionnaire survey of 240 participants in the
Autor:
Jun Nishikami, Yasuhisa Kato, Shingo Hosoe, Morihiro Okada, Hirokazu Okamoto, Tsutomu Yamada, Yoshiko Yanbe, Katsuo Amioka
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 36:689-695
The purpose of this study was to provide guidance to patients with type 2 diabetes mellitus when their insulin device was changed since insulin therapy may be hampered when a device change is made.Informed consent was obtained from the 18 patients wh
Autor:
Masaaki Takahashi, Katsuo Amioka, Toshiharu Nomura, Masaaki Shibata, Wataru Sugiura, Atsushi Hirano, Kenji Ikemura, Yoshiyuki Yokomaku
Publikováno v:
AIDS research and human retroviruses. 28(8)
Raltegravir is metabolized by glucuronidation via UDP-glucuronosyltransferase 1A1 (UGT1A1). We analyzed the genotypes of UGT1A1 (*6, *27, and *28) and their contribution to plasma raltegravir concentrations in 56 Japanese HIV-1-infected patients in t
Publikováno v:
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 127(12)
The interactions between miglitol, an alpha-glucosidase inhibitor, and six adsorbents (carbon spheres, cholestyramine, colestimide, sevelamer hydrochloride, calcium polystyrene sulfonate, and sodium polystyrene sulfonate) were investigated in vitro.
Autor:
Toshitaka Nabeshima, Atsumi Nitta, Katsuo Amioka, Hideyuki Kushihara, Masayuki Ejiri, Takafumi Kuzuya
Publikováno v:
The Journal of pharmacy and pharmacology. 59(10)
Carvedilol is often used to treat hypertension and for prophylaxis in vascular sclerosis in renal transplant recipients, who require concomitant treatment with ciclosporin. However, there are few reports regarding the pharmacokinetic interactions bet
Publikováno v:
Epilepsy research. 51(3)
The effect of valproic acid (VPA) on the copper absorption and disposition in rat small intestine was investigated using an in situ recirculating perfusion method. Following addition of VPA (20 mg) to the perfusion of 30 ml of 0.9% sodium chloride so
Autor:
Katsuo Amioka, Takafumi Kuzuya, Hideyuki Kushihara, Masayuki Ejiri, Atsumi Nitta, Toshitaka Nabeshima
Publikováno v:
Journal of Pharmacy & Pharmacology; Oct2007, Vol. 59 Issue 10, p1383-1387, 5p
Autor:
Hatsue Aoki, Shin-ichi Terao, Sawao Ishikawa, Akio Takeda, Hiroshi Hishida, Katsuo Amioka, Yasutaka Sakamoto
Publikováno v:
Journal of the Japan Epilepsy Society. 7:152-159
バルプロ酸 (VPA) の徐放錠KW-6066Nを用い, 健常人8名の連続投与試験と, 本剤服用中の原発全般てんかん (PGE) 4例, 部分てんかん (PE) 7例, 続発全般てんかん (SGE) 2例, 計13例のVPA定常状態濃度の
Autor:
Katsuo Amioka
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 19:229-230